Free Trial
→ Trump’s treachery (From Porter & Company) (Ad) Buy MET Stock  Free MET Stock Alerts

MetLife (MET) Financials

MetLife logo
$77.92 -2.41 (-2.99%)
Closing price 03:59 PM Eastern
Extended Trading
$77.92 0.00 (-0.01%)
As of 06:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for MetLife

Annual Income Statements for MetLife

This table shows MetLife's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders		 4,226 1,380 5,099 6,654 5,191 5,721 4,982 3,907 747 5,215
Consolidated Net Income / (Loss)		 4,444 1,602 5,302 6,876 5,418 5,909 5,128 4,020 854 5,385
Net Income / (Loss) Continuing Operations		 4,444 1,602 5,302 6,876 5,418 5,909 5,128 5,006 3,588 4,061
Total Pre-Tax Income 		5,622 2,162 6,364 8,518 6,927 6,795 6,307 3,536 4,281 5,651
Total Revenue		 72,095 67,899 72,444 68,696 67,842 69,620 67,941 62,308 60,787 61,343
Net Interest Income / (Expense)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income		 72,095 67,899 72,444 68,696 67,842 69,620 67,941 62,308 60,787 61,343
Other Service Charges		 7,575 7,678 7,855 7,863 7,452 7,445 7,382 6,851 7,168 7,497
Net Realized & Unrealized Capital Gains on Investments		 18,466 14,944 12,405 19,681 18,356 19,940 16,719 16,465 16,417 17,443
Premiums Earned		 44,945 44,283 48,510 41,152 42,034 42,235 43,840 38,992 37,202 36,403
Other Non-Interest Income		 1,109 994 3,674 - - - - - - -
Total Non-Interest Expense		 66,473 65,737 66,080 60,178 60,915 62,825 61,634 58,772 56,506 55,692
Property & Liability Insurance Claims		 53,067 52,450 53,401 48,517 46,675 47,925 46,669 43,920 41,534 39,559
Insurance Policy Acquisition Costs		 595 622 706 880 1,090 1,211 1,251 1,231 1,223 1,356
Other Operating Expenses		 12,811 12,665 11,973 12,018 13,150 13,689 13,714 13,621 13,749 14,777
Income Tax Expense		 1,178 560 1,062 1,642 1,509 886 1,179 -1,470 693 1,590
Preferred Stock Dividends Declared		 200 198 185 201 216 178 141 103 103 158
Net Income / (Loss) Attributable to Noncontrolling Interest		 18 24 18 21 11 10 5.00 10 4.00 12
Basic Earnings per Share		 $5.98 $1.82 $6.35 $7.71 $5.72 $6.10 $4.95 $3.65 $0.68 $4.67
Weighted Average Basic Shares Outstanding		 681.23M 723.02M 774.36M 825.08M 884.40M 915.83M 1.01B 1.07B 1.10B 1.12B
Diluted Earnings per Share		 $5.94 $1.81 $6.30 $7.65 $5.68 $6.06 $4.91 $3.62 $0.67 $4.62
Weighted Average Diluted Shares Outstanding		 681.23M 723.02M 774.36M 825.08M 884.40M 915.83M 1.01B 1.07B 1.10B 1.12B
Weighted Average Basic & Diluted Shares Outstanding		 681.23M 723.02M 774.36M 825.08M 884.40M 915.83M 1.01B 1.07B 1.10B 1.12B
Cash Dividends to Common per Share		 $2.16 $2.06 $1.98 $1.90 $1.82 $1.74 $1.66 $1.60 $1.58 $1.48

Quarterly Income Statements for MetLife

This table shows MetLife's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 879 1,239 1,275 912 800 574 422 370 14 1,549 1,098
Consolidated Net Income / (Loss)		 950 1,275 1,341 953 875 614 495 408 85 1,581 1,167
Net Income / (Loss) Continuing Operations		 950 1,275 1,341 953 875 614 495 408 85 1,581 1,167
Total Pre-Tax Income 		1,354 1,381 1,994 1,202 1,045 941 534 430 257 2,026 1,415
Total Revenue		 18,569 19,612 17,909 17,823 16,751 20,210 15,866 16,623 15,200 17,842 22,283
Net Interest Income / (Expense)		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Income		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Non-Interest Income		 18,569 19,612 17,909 17,823 16,751 20,210 15,866 16,623 15,200 17,842 22,283
Other Service Charges		 1,916 1,858 1,876 1,919 1,922 1,901 1,940 1,909 1,928 1,893 2,003
Net Realized & Unrealized Capital Gains on Investments		 4,930 4,191 5,917 4,276 4,082 5,341 2,696 3,036 3,871 4,710 2,948
Premiums Earned		 11,723 12,617 10,647 11,628 10,053 11,786 11,230 11,678 9,589 9,005 17,332
Total Non-Interest Expense		 17,215 18,231 15,915 16,621 15,706 19,269 15,332 16,193 14,943 15,816 20,868
Property & Liability Insurance Claims		 13,422 14,594 12,634 13,475 12,364 14,217 12,771 13,726 11,736 10,706 18,753
Insurance Policy Acquisition Costs		 144 150 150 148 147 159 153 151 159 155 158
Other Operating Expenses		 3,350 3,305 3,131 3,180 3,195 3,280 3,204 3,133 3,048 3,233 2,922
Other Special Charges		 299 - - -182 - - -796 -817 - - -965
Income Tax Expense		 404 106 653 249 170 327 39 22 172 445 248
Preferred Stock Dividends Declared		 66 32 67 34 67 33 67 32 66 29 64
Net Income / (Loss) Attributable to Noncontrolling Interest		 5.00 4.00 -1.00 7.00 8.00 7.00 6.00 6.00 5.00 3.00 5.00
Basic Earnings per Share		 $1.29 $1.77 $1.82 $1.28 $1.11 $0.76 $0.56 $0.48 $0.02 $1.97 $1.38
Weighted Average Basic Shares Outstanding		 671.30M 681.23M 692.42M 700.32M 711.12M 723.02M 740.19M 752.02M 765.82M 774.36M 784.61M
Diluted Earnings per Share		 $1.28 $1.75 $1.81 $1.28 $1.10 $0.75 $0.56 $0.48 $0.02 $1.96 $1.37
Weighted Average Diluted Shares Outstanding		 671.30M 681.23M 692.42M 700.32M 711.12M 723.02M 740.19M 752.02M 765.82M 774.36M 784.61M
Weighted Average Basic & Diluted Shares Outstanding		 671.30M 681.23M 692.42M 700.32M 711.12M 723.02M 740.19M 752.02M 765.82M 774.36M 784.61M
Cash Dividends to Common per Share		 $0.55 - $0.55 $0.55 $0.52 - $0.52 $0.52 $0.50 - $0.50

Annual Cash Flow Statements for MetLife

This table details how cash moves in and out of MetLife's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents		 -571 444 79 -444 3,962 777 3,120 -5,176 5,125 1,944
Net Cash From Operating Activities		 14,598 13,721 13,044 12,347 11,639 13,786 11,738 12,283 14,774 14,052
Net Cash From Continuing Operating Activities		 14,598 13,721 13,044 12,347 11,639 13,786 11,738 12,283 14,774 14,052
Net Income / (Loss) Continuing Operations		 4,444 1,602 5,302 6,876 5,418 5,909 5,128 4,020 854 5,385
Consolidated Net Income / (Loss)		 4,444 1,602 5,302 6,876 5,418 5,909 5,128 4,020 854 5,385
Depreciation Expense		 714 718 673 694 619 630 628 795 652 693
Amortization Expense		 -1,512 -1,332 -992 -874 -816 -999 -1,013 -1,044 -1,110 -1,141
Non-Cash Adjustments to Reconcile Net Income		 8,804 10,627 2,615 1,321 1,565 821 -1,209 2,903 6,545 -2,511
Changes in Operating Assets and Liabilities, net		 2,148 2,106 5,446 4,330 4,853 7,425 8,204 5,609 7,833 11,626
Net Cash From Investing Activities		 -11,493 -10,246 -2,620 -11,187 -18,569 -17,586 -5,634 -16,876 -5,850 -10,398
Net Cash From Continuing Investing Activities		 -11,493 -10,246 -2,620 -11,187 -18,569 -17,586 -5,634 -16,876 -5,850 -10,398
Acquisitions		 -3,981 -5,662 -7,793 -7,990 -4,247 -3,749 -4,173 -8,696 -6,963 -4,211
Purchase of Investment Securities		 -88,213 -89,164 -116,549 -141,348 -123,132 -108,884 -125,288 -124,533 -170,240 -173,918
Divestitures		 0.00 0.00 590 3,270 0.00 0.00 - - 156 0.00
Sale and/or Maturity of Investments		 79,848 82,514 117,394 131,663 104,139 92,700 119,709 111,872 167,244 165,977
Other Investing Activities, net		 853 2,066 3,738 3,218 4,671 2,347 4,118 4,481 3,953 1,754
Net Cash From Financing Activities		 -3,131 -2,940 -9,948 -1,126 10,729 4,568 -2,801 -906 -3,497 -1,218
Net Cash From Continuing Financing Activities		 -3,131 -2,940 -9,948 -1,126 10,729 4,568 -2,801 -906 -3,497 -1,218
Issuance of Debt		 1,609 -612 -9,717 1,912 4,812 3,526 224 4,560 -3,636 5,437
Repayment of Debt		 -97,749 -92,835 -98,726 -93,791 -85,498 -86,571 -90,814 -89,197 -84,610 -96,116
Repurchase of Common Equity		 -3,207 -3,103 -3,326 -4,303 -1,151 -2,285 -3,992 -2,927 -372 -1,930
Payment of Dividends		 -1,727 -1,764 -1,783 -1,842 -1,859 -1,821 -1,819 -1,820 -1,839 -1,769
Other Financing Activities, Net		 97,943 95,374 103,604 97,398 93,467 91,719 92,326 88,478 86,960 93,179
Effect of Exchange Rate Changes		 -545 -91 -397 -478 163 9.00 -183 - -302 -492
Cash Interest Paid		 1,037 989 905 914 891 964 1,130 1,118 1,202 1,178
Cash Income Taxes Paid		 1,600 1,833 1,056 1,102 787 1,099 1,935 1,530 672 1,127

Quarterly Cash Flow Statements for MetLife

This table details how cash moves in and out of MetLife's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 -3,004 8,290 -3,190 -2,544 -3,127 14,266 -3,980 -6,077 -3,765 8,738 -2,658
Net Cash From Operating Activities		 4,262 4,611 4,169 3,490 2,328 5,182 3,475 3,038 2,026 2,301 4,310
Net Cash From Continuing Operating Activities		 0.00 14,598 - - 0.00 13,721 - - 0.00 13,044 -
Net Income / (Loss) Continuing Operations		 0.00 4,444 - - 0.00 1,602 - - 0.00 5,302 -
Net Cash From Investing Activities		 -3,322 -5,364 -2,162 -1,340 -2,627 576 -2,972 -6,346 -1,504 -197 -4,112
Net Cash From Continuing Investing Activities		 -3,322 -5,364 -2,162 -1,340 -2,627 576 -2,972 -6,346 -1,504 -197 -4,112
Acquisitions		 -1,013 -1,198 -522 -1,209 -1,052 -1,446 -1,474 -1,196 -1,546 -1,725 -1,550
Purchase of Investment Securities		 -25,279 -23,805 -21,965 -22,704 -19,739 -17,084 -22,075 -25,183 -24,822 -28,175 -26,038
Sale and/or Maturity of Investments		 21,710 20,054 19,585 22,268 17,941 17,923 20,007 20,677 23,907 28,316 22,901
Other Investing Activities, net		 1,260 -415 740 305 223 1,183 570 -644 957 1,387 575
Net Cash From Financing Activities		 220 -519 -1,146 -1,205 -261 -176 -848 379 -2,295 -4,468 1,743
Net Cash From Continuing Financing Activities		 220 -519 -1,146 -1,205 -261 -176 -848 379 -2,295 -4,468 1,743
Issuance of Debt		 1,388 309 -447 897 850 -28 111 -629 -66 -4,128 2,214
Repayment of Debt		 -27,739 -22,987 -24,455 -26,462 -23,845 -20,184 -21,915 -22,827 -27,909 -18,933 -26,999
Repurchase of Common Equity		 -1,411 -406 -774 -855 -1,172 -859 -792 -672 -780 -596 -674
Payment of Dividends		 -440 -410 -450 -423 -444 -419 -459 -431 -455 -422 -464
Other Financing Activities, Net		 28,422 22,975 24,980 25,638 24,350 21,314 22,207 24,938 26,915 19,611 27,666
Effect of Exchange Rate Changes		 98 -425 118 1.00 -239 145 -160 -110 34 359 -289
Cash Interest Paid		 224 287 223 296 231 311 206 289 183 314 156
Cash Income Taxes Paid		 147 327 279 864 130 481 236 945 171 444 35

Annual Balance Sheets for MetLife

This table presents MetLife's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets		 677,457 687,584 663,072 759,708 795,146 740,463 687,538 719,892 898,764 877,933
Cash and Due from Banks		 20,068 20,639 20,195 20,047 19,795 16,598 15,821 12,701 12,651 12,752
Trading Account Securities		 292,427 292,500 288,132 353,685 354,809 342,264 312,321 328,189 306,380 369,747
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 3,489 3,589 3,446 3,185 17,786 3,523 3,582 3,524 3,308 3,988
Mortgage Servicing Rights		 89,012 92,506 83,763 79,353 83,919 80,529 75,752 68,731 65,167 67,102
Unearned Premiums Asset		 29,761 28,971 17,364 17,149 17,870 20,443 19,644 18,423 15,445 22,702
Deferred Acquisition Cost		 19,627 20,151 19,653 16,061 16,389 17,833 18,895 18,419 17,590 24,130
Separate Account Business Assets		 139,504 144,634 146,038 179,873 199,970 188,445 175,556 205,001 195,578 301,598
Goodwill		 8,901 9,236 9,297 9,535 10,112 9,308 9,422 9,590 9,220 9,477
Other Assets		 74,668 75,358 75,184 80,820 74,496 61,520 56,545 55,314 273,425 66,437
Total Liabilities & Shareholders' Equity		 677,457 687,584 663,072 759,708 795,146 740,463 687,538 719,892 898,764 877,933
Total Liabilities		 649,754 657,331 632,947 691,959 720,329 674,081 634,580 661,022 831,062 809,437
Short-Term Debt		 32,679 17,643 35,759 32,261 29,997 40,809 25,503 26,511 26,115 36,971
Long-Term Debt		 3,640 19,346 3,874 17,855 18,601 4,143 17,036 19,951 20,884 25,356
Future Policy Benefits		 193,646 196,406 187,222 199,721 206,656 194,909 186,780 177,974 166,636 191,879
Participating Policy Holder Equity		 240,729 219,655 229,408 223,384 225,833 212,499 201,327 200,836 188,515 219,480
Separate Account Business Liabilities		 139,504 144,634 146,038 179,873 199,970 188,445 175,556 205,001 195,578 301,598
Other Long-Term Liabilities		 39,556 59,647 30,646 38,865 39,272 33,276 28,378 30,749 233,334 34,153
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 27,703 30,253 30,125 67,749 74,817 66,382 52,958 58,870 67,702 68,419
Total Preferred & Common Equity		 27,445 30,015 29,881 67,482 74,558 66,144 52,741 58,676 67,531 67,949
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 27,445 30,015 29,881 67,482 74,558 66,144 52,741 58,676 67,531 67,949
Common Stock		 33,803 33,702 33,628 33,523 33,824 32,692 32,486 31,123 30,956 30,761
Retained Earnings		 42,626 40,146 40,332 41,197 36,491 33,078 28,926 26,527 34,683 35,519
Treasury Stock		 -27,798 -24,591 -21,458 -18,157 -13,829 -12,678 -10,393 -6,401 -3,474 -3,102
Accumulated Other Comprehensive Income / (Loss)		 -21,186 -19,242 -22,621 10,919 18,072 13,052 1,722 7,427 5,366 4,771
Noncontrolling Interest		 258 238 244 267 259 238 217 194 171 470

Quarterly Balance Sheets for MetLife

This table presents MetLife's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Total Assets		 688,316 677,457 704,976 675,745 677,576 687,584 652,120 677,279 674,266 663,072 650,104
Cash and Due from Banks		 21,326 20,068 21,765 20,786 19,840 20,639 14,912 15,417 18,456 20,195 22,200
Trading Account Securities		 303,207 292,427 293,779 288,596 289,472 292,500 281,404 294,830 295,612 288,132 280,692
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 3,557 3,489 13,757 3,657 3,636 3,589 3,704 3,505 3,554 3,446 3,355
Mortgage Servicing Rights		 87,908 89,012 90,415 89,802 91,458 92,506 92,230 92,986 85,572 83,763 82,437
Unearned Premiums Asset		 31,251 29,761 31,443 31,820 29,986 28,971 19,002 18,530 18,692 17,364 17,666
Deferred Acquisition Cost		 20,162 19,627 20,401 19,568 19,842 20,151 19,737 19,850 19,976 19,653 21,523
Separate Account Business Assets		 138,143 139,504 148,809 139,707 141,003 144,634 135,624 145,946 148,417 146,038 135,771
Goodwill		 9,036 8,901 9,155 8,950 9,037 9,236 9,109 9,261 9,379 9,297 9,005
Other Assets		 73,726 74,668 75,452 72,859 73,302 75,358 76,398 76,954 74,608 75,184 77,455
Total Liabilities & Shareholders' Equity		 688,316 677,457 704,976 675,745 677,576 687,584 652,120 677,279 674,266 663,072 650,104
Total Liabilities		 660,561 649,754 673,812 648,205 648,780 657,331 626,225 646,787 641,843 632,947 624,774
Short-Term Debt		 17,821 32,679 17,536 18,109 33,569 17,643 33,492 33,545 34,653 35,759 25,073
Long-Term Debt		 19,311 3,640 18,970 18,527 3,752 19,346 3,811 3,835 3,863 3,874 18,407
Future Policy Benefits		 197,667 193,646 201,340 190,993 191,013 196,406 181,755 190,474 191,741 187,222 199,671
Participating Policy Holder Equity		 225,979 240,729 244,922 239,287 239,744 219,655 233,979 234,421 232,523 229,408 218,171
Separate Account Business Liabilities		 138,143 139,504 148,809 139,707 141,003 144,634 135,624 145,946 148,417 146,038 135,771
Other Long-Term Liabilities		 61,640 39,556 42,235 41,582 39,699 59,647 37,564 38,566 30,646 30,646 27,681
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 27,755 27,703 31,164 27,540 28,796 30,253 25,895 30,492 32,423 30,125 25,330
Total Preferred & Common Equity		 27,493 27,445 30,885 27,252 28,535 30,015 25,658 30,261 32,194 29,881 25,076
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 27,493 27,445 30,885 27,252 28,535 30,015 25,658 30,261 32,194 29,881 25,076
Common Stock		 33,832 33,803 33,778 33,752 33,730 33,702 33,678 33,642 33,629 33,628 33,601
Retained Earnings		 43,131 42,626 41,765 40,873 40,350 40,146 39,958 39,928 39,957 40,332 41,032
Treasury Stock		 -29,222 -27,798 -27,418 -26,637 -25,774 -24,591 -23,724 -22,923 -22,245 -21,458 -20,862
Accumulated Other Comprehensive Income / (Loss)		 -20,248 -21,186 -17,240 -20,736 -19,771 -19,242 -24,254 -20,386 -19,147 -22,621 -28,695
Noncontrolling Interest		 262 258 279 288 261 238 237 231 229 244 254

Annual Metrics And Ratios for MetLife

This table displays calculated financial ratios and metrics derived from MetLife's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 6.18% -6.27% 5.46% 1.26% -2.55% 2.47% 9.04% 2.50% -0.91% -16.33%
EBITDA Growth		 211.63% -74.39% -27.50% 23.89% 4.73% 8.51% 80.16% -14.02% -26.52% -41.58%
EBIT Growth		 160.04% -66.03% -25.29% 22.97% 1.94% 7.74% 78.37% -17.40% -24.24% -35.81%
NOPAT Growth		 177.40% -69.79% -22.89% 26.91% -8.31% 15.23% 2.44% 39.52% -11.65% -35.94%
Net Income Growth		 177.40% -69.79% -22.89% 26.91% -8.31% 15.23% 27.56% 370.73% -84.14% -15.01%
EPS Growth		 228.18% -71.27% -17.65% 34.68% -6.27% 23.42% 35.64% 440.30% -84.14% -15.01%
Operating Cash Flow Growth		 6.39% 5.19% 5.65% 6.08% -15.57% 17.45% -4.44% -16.86% 5.14% -14.19%
Free Cash Flow Firm Growth		 86.11% -92.29% 329.82% 286.49% 32.89% -166.35% 4.09% -27.07% 294.36% 186.02%
Invested Capital Growth		 -4.79% -3.61% -40.82% -4.50% 10.85% 16.58% -9.34% -8.17% -12.32% -0.71%
Revenue Q/Q Growth		 -0.82% 3.61% 0.19% -2.43% 3.47% 2.17% -0.26% 7.93% 4.88% -14.83%
EBITDA Q/Q Growth		 -6.91% -52.33% 0.15% 19.39% 0.06% -30.93% 23.45% 14.93% 15.43% -38.14%
EBIT Q/Q Growth		 8.49% -33.42% 5.43% 21.96% 2.99% -26.96% 31.48% 23.64% 29.26% -32.81%
NOPAT Q/Q Growth		 17.47% -37.64% 1.32% 24.52% -7.35% -19.96% -4.70% 70.39% 22.79% -32.40%
Net Income Q/Q Growth		 17.47% -37.64% 1.32% 24.52% -7.35% -19.96% -4.70% 1,314.50% -77.50% -10.35%
EPS Q/Q Growth		 20.24% -40.07% 3.96% 25.41% -6.89% -22.51% -7.53% 941.86% -77.50% -10.35%
Operating Cash Flow Q/Q Growth		 -3.76% 26.58% -17.62% -0.50% -0.24% 39.17% -6.00% -22.63% 8.19% -6.03%
Free Cash Flow Firm Q/Q Growth		 1,212.34% -49.66% -3.69% -13.92% 8.19% 14.83% 0.27% -67.69% 283.98% 177.20%
Invested Capital Q/Q Growth		 -5.39% 6.40% 1.38% -0.98% -3.54% -3.05% -0.32% -0.01% -21.92% -1.83%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 6.69% 2.28% 8.34% 12.14% 9.92% 9.23% 8.72% 5.28% 6.29% 8.48%
EBIT Margin		 7.80% 3.18% 8.78% 12.40% 10.21% 9.76% 9.28% 5.68% 7.04% 9.21%
Profit (Net Income) Margin		 6.16% 2.36% 7.32% 10.01% 7.99% 8.49% 7.55% 6.45% 1.40% 8.78%
Tax Burden Percent		 79.05% 74.10% 83.31% 80.72% 78.22% 86.96% 81.31% 113.69% 19.95% 95.29%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 20.95% 25.90% 16.69% 19.28% 21.78% 13.04% 18.69% -41.57% 16.19% 28.14%
Return on Invested Capital (ROIC)		 6.77% 2.34% 5.65% 5.70% 4.62% 5.71% 5.11% 4.55% 2.92% 3.09%
ROIC Less NNEP Spread (ROIC-NNEP)		 6.77% 2.34% 5.65% 5.70% 4.62% 5.71% 5.11% 2.44% -2.08% 5.27%
Return on Net Nonoperating Assets (RNNOA)		 8.56% 2.97% 5.18% 3.95% 3.06% 4.19% 4.06% 1.80% -1.67% 4.54%
Return on Equity (ROE)		 15.34% 5.31% 10.83% 9.65% 7.67% 9.90% 9.17% 6.35% 1.25% 7.63%
Cash Return on Invested Capital (CROIC)		 11.68% 6.01% 56.93% 10.30% -5.68% -9.60% 14.90% 13.07% 16.06% 3.81%
Operating Return on Assets (OROA)		 0.82% 0.32% 0.89% 1.10% 0.90% 0.95% 0.90% 0.44% 0.48% 0.63%
Return on Assets (ROA)		 0.65% 0.24% 0.75% 0.88% 0.71% 0.83% 0.73% 0.50% 0.10% 0.61%
Return on Common Equity (ROCE)		 15.20% 5.26% 10.78% 9.61% 7.65% 9.87% 9.14% 6.33% 1.25% 7.57%
Return on Equity Simple (ROE_SIMPLE)		 16.19% 5.34% 17.74% 10.19% 7.27% 8.93% 9.72% 6.85% 1.26% 7.93%
Net Operating Profit after Tax (NOPAT)		 4,444 1,602 5,302 6,876 5,418 5,909 5,128 5,006 3,588 4,061
NOPAT Margin		 6.16% 2.36% 7.32% 10.01% 7.99% 8.49% 7.55% 8.03% 5.90% 6.62%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.11% 5.00% -2.18%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 92.20% 96.82% 91.22% 87.60% 89.79% 90.24% 90.72% 94.33% 92.96% 90.79%
Earnings before Interest and Taxes (EBIT)		 5,622 2,162 6,364 8,518 6,927 6,795 6,307 3,536 4,281 5,651
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 4,824 1,548 6,045 8,338 6,730 6,426 5,922 3,287 3,823 5,203
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 2.05 1.57 1.77 0.71 0.50 0.60 0.63 0.71 0.67 0.58
Price to Tangible Book Value (P/TBV)		 3.04 2.27 2.57 0.83 0.58 0.70 0.76 0.85 0.78 0.68
Price to Revenue (P/Rev)		 0.78 0.69 0.73 0.70 0.55 0.57 0.49 0.67 0.74 0.64
Price to Earnings (P/E)		 13.33 34.18 10.38 7.25 7.23 6.94 6.64 10.72 60.58 7.58
Dividend Yield		 2.65% 3.23% 2.94% 3.32% 4.36% 4.03% 4.95% 3.70% 3.83% 4.15%
Earnings Yield		 7.50% 2.93% 9.64% 13.80% 13.83% 14.41% 15.06% 9.33% 1.65% 13.20%
Enterprise Value to Invested Capital (EV/IC)		 1.14 0.95 1.04 0.67 0.54 0.61 0.63 0.72 0.70 0.69
Enterprise Value to Revenue (EV/Rev)		 1.01 0.94 1.00 1.14 0.98 0.98 0.88 1.22 1.31 1.46
Enterprise Value to EBITDA (EV/EBITDA)		 15.10 41.19 12.01 9.42 9.89 10.63 10.13 23.07 20.87 17.23
Enterprise Value to EBIT (EV/EBIT)		 12.96 29.49 11.41 9.22 9.61 10.05 9.51 21.44 18.63 15.86
Enterprise Value to NOPAT (EV/NOPAT)		 16.39 39.80 13.69 11.42 12.29 11.56 11.70 15.15 22.23 22.07
Enterprise Value to Operating Cash Flow (EV/OCF)		 4.99 4.65 5.56 6.36 5.72 4.95 5.11 6.17 5.40 6.38
Enterprise Value to Free Cash Flow (EV/FCFF)		 9.50 15.48 1.36 6.32 0.00 0.00 4.01 5.27 4.05 17.93
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 1.31 1.22 1.32 0.74 0.65 0.68 0.80 0.79 0.69 0.91
Long-Term Debt to Equity		 0.13 0.64 0.13 0.26 0.25 0.06 0.32 0.34 0.31 0.37
Financial Leverage		 1.26 1.27 0.92 0.69 0.66 0.73 0.80 0.74 0.80 0.86
Leverage Ratio		 23.55 22.37 14.54 10.91 10.88 11.97 12.59 12.79 13.05 12.61
Compound Leverage Factor		 23.55 22.37 14.54 10.91 10.88 11.97 12.59 12.79 13.05 12.61
Debt to Total Capital		 56.73% 55.01% 56.82% 42.52% 39.38% 40.38% 44.54% 44.11% 40.98% 47.64%
Short-Term Debt to Total Capital		 51.04% 26.24% 51.26% 27.37% 24.31% 36.65% 26.71% 25.17% 22.77% 28.26%
Long-Term Debt to Total Capital		 5.69% 28.77% 5.55% 15.15% 15.07% 3.72% 17.84% 18.94% 18.21% 19.38%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.40% 0.35% 0.35% 0.23% 0.21% 0.21% 0.23% 0.18% 0.15% 0.42%
Common Equity to Total Capital		 42.87% 44.64% 42.84% 57.25% 60.41% 59.41% 55.23% 55.71% 58.88% 51.94%
Debt to EBITDA		 7.53 23.89 6.56 6.01 7.22 7.00 7.18 14.14 12.29 11.98
Net Debt to EBITDA		 3.37 10.56 3.22 3.61 4.28 4.41 4.51 10.27 8.98 9.53
Long-Term Debt to EBITDA		 0.75 12.50 0.64 2.14 2.76 0.64 2.88 6.07 5.46 4.87
Debt to NOPAT		 8.17 23.09 7.48 7.29 8.97 7.61 8.30 9.28 13.10 15.35
Net Debt to NOPAT		 3.66 10.21 3.67 4.37 5.32 4.80 5.21 6.74 9.57 12.21
Long-Term Debt to NOPAT		 0.82 12.08 0.73 2.60 3.43 0.70 3.32 3.99 5.82 6.24
Noncontrolling Interest Sharing Ratio		 0.86% 0.80% 0.52% 0.37% 0.35% 0.38% 0.37% 0.29% 0.53% 0.82%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 7,664 4,118 53,409 12,426 -6,663 -9,928 14,963 14,375 19,710 4,998
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.11 0.10 0.10 0.09 0.09 0.10 0.10 0.08 0.07 0.07
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 64,022 67,242 69,758 117,865 123,415 111,334 95,497 105,332 114,701 130,823
Invested Capital Turnover		 1.10 0.99 0.77 0.57 0.58 0.67 0.68 0.57 0.50 0.47
Increase / (Decrease) in Invested Capital		 -3,220 -2,516 -48,107 -5,550 12,081 15,837 -9,835 -9,369 -16,122 -937
Enterprise Value (EV)		 72,843 63,755 72,586 78,544 66,593 68,300 60,008 75,822 79,773 89,626
Market Capitalization		 56,334 47,167 52,904 48,208 37,531 39,708 33,073 41,867 45,254 39,504
Book Value per Share		 $39.64 $40.55 $38.08 $80.22 $82.85 $71.92 $53.44 $55.76 $61.44 $61.13
Tangible Book Value per Share		 $26.78 $28.07 $26.23 $68.89 $71.61 $61.80 $43.90 $46.65 $53.05 $52.60
Total Capital		 64,022 67,242 69,758 117,865 123,415 111,334 95,497 105,332 114,701 130,823
Total Debt		 36,319 36,989 39,633 50,116 48,598 44,952 42,539 46,462 46,999 62,327
Total Long-Term Debt		 3,640 19,346 3,874 17,855 18,601 4,143 17,036 19,951 20,884 25,356
Net Debt		 16,251 16,350 19,438 30,069 28,803 28,354 26,718 33,761 34,348 49,575
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 986 2,734 -1,324
Net Nonoperating Obligations (NNO)		 36,319 36,989 39,633 50,116 48,598 44,952 42,539 46,462 46,999 62,327
Total Depreciation and Amortization (D&A)		 -798 -614 -319 -180 -197 -369 -385 -249 -458 -448
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $5.98 $1.82 $2.93 $7.36 $5.72 $6.10 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 681.23M 723.02M 774.36M 825.08M 884.40M 915.83M 0.00 0.00 0.00 0.00
Adjusted Diluted Earnings per Share		 $5.94 $1.81 $2.91 $7.31 $5.68 $6.06 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 681.23M 723.02M 774.36M 825.08M 884.40M 915.83M 0.00 0.00 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 681.23M 723.02M 774.36M 825.08M 884.40M 915.83M 0.00 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 4,444 1,602 5,302 5,877 5,418 5,909 5,128 2,475 3,588 4,061
Normalized NOPAT Margin		 6.16% 2.36% 7.32% 8.56% 7.99% 8.49% 7.55% 3.97% 5.90% 6.62%
Pre Tax Income Margin		 7.80% 3.18% 8.78% 12.40% 10.21% 9.76% 9.28% 5.68% 7.04% 9.21%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 38.86% 110.11% 33.63% 26.79% 34.31% 30.82% 35.47% 45.27% 215.34% 32.85%
Augmented Payout Ratio		 111.03% 303.81% 96.36% 89.37% 55.56% 69.49% 113.32% 118.08% 258.90% 68.69%

Quarterly Metrics And Ratios for MetLife

This table displays calculated financial ratios and metrics derived from MetLife's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 10.85% -2.96% 12.88% 7.22% 10.20% 13.27% -28.80% 7.43% -9.77% 0.77% 31.81%
EBITDA Growth		 29.57% 46.76% 273.41% 179.53% 306.61% -53.55% -62.26% -56.48% -86.72% 19.32% -30.71%
EBIT Growth		 29.57% 46.76% 273.41% 179.53% 306.61% -53.55% -62.26% -56.48% -86.72% 19.32% -30.71%
NOPAT Growth		 8.57% 107.65% 170.91% 133.58% 929.41% -61.16% -57.58% -55.41% -94.81% 4.56% -26.56%
Net Income Growth		 8.57% 107.65% 170.91% 133.58% 929.41% -61.16% -57.58% -55.41% -94.81% 4.56% -26.56%
EPS Growth		 16.36% 133.33% 223.21% 166.67% 5,400.00% -61.73% -59.12% -55.56% -98.94% 13.95% -22.60%
Operating Cash Flow Growth		 83.08% -11.02% 19.97% 14.88% 14.91% 125.21% -19.37% -30.84% -0.69% -54.80% 22.93%
Free Cash Flow Firm Growth		 -61.73% 43.61% -151.27% -59.55% -82.17% -93.70% -88.12% -71.89% 156.22% 603.60% 389.33%
Invested Capital Growth		 -1.86% -4.79% 7.08% -5.45% -6.80% -3.61% -8.16% -14.04% -30.99% -40.82% -42.19%
Revenue Q/Q Growth		 -5.32% 9.51% 0.48% 6.40% -13.72% 27.38% -4.55% 9.36% -14.81% -19.93% 44.00%
EBITDA Q/Q Growth		 -1.96% -30.74% 65.89% 15.02% 11.05% 76.22% 24.19% 67.32% -87.31% 43.18% 43.22%
EBIT Q/Q Growth		 -1.96% -30.74% 65.89% 15.02% 11.05% 76.22% 24.19% 67.32% -87.31% 43.18% 43.22%
NOPAT Q/Q Growth		 -25.49% -4.92% 40.71% 8.91% 42.51% 24.04% 21.32% 380.00% -94.62% 35.48% 27.54%
Net Income Q/Q Growth		 -25.49% -4.92% 40.71% 8.91% 42.51% 24.04% 21.32% 380.00% -94.62% 35.48% 27.54%
EPS Q/Q Growth		 -26.86% -3.31% 41.41% 16.36% 46.67% 33.93% 16.67% 2,300.00% -98.98% 43.07% 26.85%
Operating Cash Flow Q/Q Growth		 -7.57% 10.60% 19.46% 49.91% -55.08% 49.12% 14.38% 49.95% -11.95% -46.61% -1.89%
Free Cash Flow Firm Q/Q Growth		 -51.50% 243.56% -167.35% -18.40% 82.01% -48.75% -46.86% -64.02% -35.71% -3.31% 25.69%
Invested Capital Q/Q Growth		 1.35% -5.39% 5.44% -2.94% -1.67% 6.40% -6.89% -4.32% 1.69% 1.38% -12.85%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 7.29% 7.04% 11.13% 6.74% 6.24% 4.66% 3.37% 2.59% 1.69% 11.36% 6.35%
EBIT Margin		 7.29% 7.04% 11.13% 6.74% 6.24% 4.66% 3.37% 2.59% 1.69% 11.36% 6.35%
Profit (Net Income) Margin		 5.12% 6.50% 7.49% 5.35% 5.22% 3.04% 3.12% 2.45% 0.56% 8.86% 5.24%
Tax Burden Percent		 70.16% 92.32% 67.25% 79.28% 83.73% 65.25% 92.70% 94.88% 33.07% 78.04% 82.47%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 29.84% 7.68% 32.75% 20.72% 16.27% 34.75% 7.30% 5.12% 66.93% 21.96% 17.53%
Return on Invested Capital (ROIC)		 5.77% 7.14% 8.32% 5.72% 5.29% 3.01% 3.10% 2.41% 0.46% 6.84% 4.03%
ROIC Less NNEP Spread (ROIC-NNEP)		 5.77% 7.14% 8.32% 5.72% 5.29% 3.01% 3.10% 2.41% 0.46% 6.84% 4.03%
Return on Net Nonoperating Assets (RNNOA)		 7.60% 9.03% 10.76% 7.30% 6.56% 3.82% 4.88% 2.80% 0.46% 6.27% 3.97%
Return on Equity (ROE)		 13.37% 16.17% 19.08% 13.02% 11.85% 6.83% 7.98% 5.20% 0.91% 13.12% 8.00%
Cash Return on Invested Capital (CROIC)		 8.78% 11.68% -1.05% 10.05% 10.53% 6.01% 12.39% 19.51% 40.99% 56.93% 59.04%
Operating Return on Assets (OROA)		 0.79% 0.74% 1.19% 0.70% 0.64% 0.47% 0.34% 0.28% 0.17% 1.16% 0.65%
Return on Assets (ROA)		 0.55% 0.69% 0.80% 0.56% 0.54% 0.31% 0.31% 0.26% 0.06% 0.90% 0.54%
Return on Common Equity (ROCE)		 13.25% 16.04% 18.91% 12.90% 11.76% 6.78% 7.91% 5.17% 0.91% 13.05% 7.96%
Return on Equity Simple (ROE_SIMPLE)		 16.44% 0.00% 12.25% 10.78% 8.38% 0.00% 10.01% 10.71% 11.64% 0.00% 20.87%
Net Operating Profit after Tax (NOPAT)		 950 1,275 1,341 953 875 614 495 408 85 1,581 1,167
NOPAT Margin		 5.12% 6.50% 7.49% 5.35% 5.22% 3.04% 3.12% 2.45% 0.56% 8.86% 5.24%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 92.71% 92.96% 88.87% 93.26% 93.76% 95.34% 96.63% 97.41% 98.31% 88.64% 93.65%
Earnings before Interest and Taxes (EBIT)		 1,354 1,381 1,994 1,202 1,045 941 534 430 257 2,026 1,415
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,354 1,381 1,994 1,202 1,045 941 534 430 257 2,026 1,415
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.99 2.05 1.87 1.82 1.89 1.57 1.79 1.37 1.33 1.77 1.81
Price to Tangible Book Value (P/TBV)		 2.96 3.04 2.66 2.71 2.77 2.27 2.77 1.98 1.87 2.57 2.83
Price to Revenue (P/Rev)		 0.74 0.78 0.79 0.70 0.78 0.69 0.70 0.58 0.60 0.73 0.63
Price to Earnings (P/E)		 12.71 13.33 16.22 18.28 24.93 34.18 19.45 13.71 12.05 10.38 9.04
Dividend Yield		 2.72% 2.65% 2.58% 3.02% 2.85% 3.23% 3.35% 3.72% 3.63% 2.94% 3.44%
Earnings Yield		 7.87% 7.50% 6.16% 5.47% 4.01% 2.93% 5.14% 7.29% 8.30% 9.64% 11.06%
Enterprise Value to Invested Capital (EV/IC)		 1.09 1.14 1.08 1.02 1.09 0.95 1.08 0.94 0.89 1.04 0.97
Enterprise Value to Revenue (EV/Rev)		 0.96 1.01 1.00 0.93 1.03 0.94 1.04 0.89 0.89 1.00 0.93
Enterprise Value to EBITDA (EV/EBITDA)		 11.93 15.10 14.05 17.64 24.32 41.19 21.07 15.45 13.44 12.01 11.10
Enterprise Value to EBIT (EV/EBIT)		 11.93 12.96 14.05 17.64 24.32 29.49 21.07 15.45 13.44 11.41 11.10
Enterprise Value to NOPAT (EV/NOPAT)		 15.66 16.39 19.24 22.35 29.99 39.80 26.64 19.67 16.80 13.69 12.80
Enterprise Value to Operating Cash Flow (EV/OCF)		 4.28 4.99 4.80 4.54 5.12 4.65 6.31 5.46 4.83 5.56 4.23
Enterprise Value to Free Cash Flow (EV/FCFF)		 12.31 9.50 0.00 9.90 9.94 15.48 8.36 4.45 1.77 1.36 1.21
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.34 1.31 1.17 1.33 1.30 1.22 1.44 1.23 1.19 1.32 1.72
Long-Term Debt to Equity		 0.70 0.13 0.61 0.67 0.13 0.64 0.15 0.13 0.12 0.13 0.73
Financial Leverage		 1.32 1.26 1.29 1.28 1.24 1.27 1.58 1.16 1.00 0.92 0.98
Leverage Ratio		 24.15 23.55 23.78 23.32 22.08 22.37 25.42 19.75 16.14 14.54 14.91
Compound Leverage Factor		 24.15 23.55 23.78 23.32 22.08 22.37 25.42 19.75 16.14 14.54 14.91
Debt to Total Capital		 57.23% 56.73% 53.95% 57.09% 56.45% 55.01% 59.03% 55.07% 54.29% 56.82% 63.19%
Short-Term Debt to Total Capital		 27.46% 51.04% 25.91% 28.22% 50.77% 26.24% 53.00% 49.42% 48.85% 51.26% 36.44%
Long-Term Debt to Total Capital		 29.76% 5.69% 28.03% 28.87% 5.67% 28.77% 6.03% 5.65% 5.45% 5.55% 26.75%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.40% 0.40% 0.41% 0.45% 0.39% 0.35% 0.38% 0.34% 0.32% 0.35% 0.37%
Common Equity to Total Capital		 42.37% 42.87% 45.64% 42.46% 43.16% 44.64% 40.60% 44.59% 45.38% 42.84% 36.44%
Debt to EBITDA		 6.26 7.53 7.04 9.84 12.65 23.89 11.49 9.06 8.22 6.56 7.20
Net Debt to EBITDA		 2.67 3.37 2.84 4.26 5.93 10.56 6.90 5.32 4.28 3.22 3.53
Long-Term Debt to EBITDA		 3.26 0.75 3.66 4.98 1.27 12.50 1.17 0.93 0.82 0.64 3.05
Debt to NOPAT		 8.22 8.17 9.65 12.47 15.60 23.09 14.52 11.53 10.28 7.48 8.31
Net Debt to NOPAT		 3.50 3.66 3.90 5.40 7.31 10.21 8.72 6.78 5.35 3.67 4.07
Long-Term Debt to NOPAT		 4.27 0.82 5.01 6.31 1.57 12.08 1.48 1.18 1.03 0.73 3.52
Noncontrolling Interest Sharing Ratio		 0.92% 0.86% 0.90% 0.89% 0.80% 0.80% 0.96% 0.73% 0.58% 0.52% 0.57%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 2,180 4,495 -3,131 4,649 5,697 3,130 6,107 11,493 31,945 49,688 51,389
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.11 0.11 0.11 0.10 0.10 0.10 0.10 0.11 0.10 0.10 0.10
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 64,887 64,022 67,670 64,176 66,117 67,242 63,198 67,872 70,939 69,758 68,810
Invested Capital Turnover		 1.13 1.10 1.11 1.07 1.01 0.99 0.99 0.98 0.82 0.77 0.77
Increase / (Decrease) in Invested Capital		 -1,230 -3,220 4,472 -3,696 -4,822 -2,516 -5,612 -11,085 -31,860 -48,107 -50,222
Enterprise Value (EV)		 70,764 72,843 72,783 65,651 71,737 63,755 68,428 63,762 62,959 72,586 67,000
Market Capitalization		 54,696 56,334 57,763 49,513 53,995 47,167 45,800 41,568 42,670 52,904 45,466
Book Value per Share		 $40.36 $39.64 $44.10 $38.32 $40.13 $40.55 $34.12 $39.51 $41.57 $38.08 $31.44
Tangible Book Value per Share		 $27.09 $26.78 $31.03 $25.74 $27.42 $28.07 $22.01 $27.42 $29.46 $26.23 $20.15
Total Capital		 64,887 64,022 67,670 64,176 66,117 67,242 63,198 67,872 70,939 69,758 68,810
Total Debt		 37,132 36,319 36,506 36,636 37,321 36,989 37,303 37,380 38,516 39,633 43,480
Total Long-Term Debt		 19,311 3,640 18,970 18,527 3,752 19,346 3,811 3,835 3,863 3,874 18,407
Net Debt		 15,806 16,251 14,741 15,850 17,481 16,350 22,391 21,963 20,060 19,438 21,280
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)		 37,132 36,319 36,506 36,636 37,321 36,989 37,303 37,380 38,516 39,633 43,480
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.29 $1.77 $1.82 $1.28 $1.11 $0.76 $0.56 $0.48 $0.02 $1.97 $0.42
Adjusted Weighted Average Basic Shares Outstanding		 671.30M 681.23M 692.42M 700.32M 711.12M 723.02M 740.19M 752.02M 765.82M 774.36M 784.61M
Adjusted Diluted Earnings per Share		 $1.28 $1.75 $1.81 $1.28 $1.10 $0.75 $0.56 $0.48 $0.02 $1.96 $0.41
Adjusted Weighted Average Diluted Shares Outstanding		 671.30M 681.23M 692.42M 700.32M 711.12M 723.02M 740.19M 752.02M 765.82M 774.36M 784.61M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 671.30M 681.23M 692.42M 700.32M 711.12M 723.02M 740.19M 752.02M 765.82M 774.36M 784.61M
Normalized Net Operating Profit after Tax (NOPAT)		 1,160 1,275 1,341 809 875 614 -243 -367 180 1,581 371
Normalized NOPAT Margin		 6.25% 6.50% 7.49% 4.54% 5.22% 3.04% -1.53% -2.21% 1.18% 8.86% 1.67%
Pre Tax Income Margin		 7.29% 7.04% 11.13% 6.74% 6.24% 4.66% 3.37% 2.59% 1.69% 11.36% 6.35%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 38.13% 38.86% 45.89% 59.41% 73.29% 110.11% 68.78% 54.67% 47.44% 33.63% 34.30%
Augmented Payout Ratio		 114.38% 111.03% 142.64% 184.64% 219.40% 303.81% 179.33% 138.66% 131.91% 96.36% 108.94%

Frequently Asked Questions About MetLife's Financials

When does MetLife's financial year end?

According to the most recent income statement we have on file, MetLife's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has MetLife's net income changed over the last 9 years?
The last 5 years of MetLife's net income performance:
  • 2020: $5.42 billion
  • 2021: $6.88 billion
  • 2022: $5.30 billion
  • 2023: $1.60 billion
  • 2024: $4.44 billion
Find out what analysts predict for MetLife in the coming months.
How has MetLife revenue changed over the last 9 years?

Over the last 9 years, MetLife's total revenue changed from $61.34 billion in 2015 to $72.10 billion in 2024, a change of 17.5%.

How much debt does MetLife have?

MetLife's total liabilities were at $649.75 billion at the end of 2024, a 1.2% decrease from 2023, and a 19.7% decrease since 2015.

How much cash does MetLife have?

In the past 9 years, MetLife's cash and equivalents has ranged from $12.65 billion in 2016 to $20.64 billion in 2023, and is currently $20.07 billion as of their latest financial filing in 2024.

How has MetLife's book value per share changed over the last 9 years?

Over the last 9 years, MetLife's book value per share changed from 61.13 in 2015 to 39.64 in 2024, a change of -35.2%.


Related Companies

This page (NYSE:MET) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Elon Set to Shock the World on June 1st?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
Massive new energy source found in Utah
NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...
Stansberry Research | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Gold Alert: The Truth About Fort Knox Is Coming
Owning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...
Golden Portfolio | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
The July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...
Crypto Swap Profits | Sponsored